Abstract

Purpose: It is very essential to diagnose gastric atrophy in the area with high prevalence of gastric cancer. Operative link for gastritis assessment (OLGA) was developed to detect the severity of gastric atrophy. The aim of this study was to develop and validate nomograms for predicting OLGA any-stage and stages III–IV in the Chinese high-risk gastric cancer population.Methods: We retrospectively analyzed 7,945 participants obtained by a multicenter cross-sectional study. We randomly selected 55% individuals (4,370 participants, training cohort) to analyze and generate the prediction models and validated the models on the remaining individuals (3,575 participants, validation cohort). A multivariate logistic regression model was used to select variables in the training cohort. The corresponding nomograms were developed to predict OLGA any-stage and stages III–IV, respectively. The area under the receiver operating characteristic curves and the GiViTI calibration belts were used to estimate the discrimination and calibration of the prediction models.Results: There were 1,226 (28.05%) participants in the training sample and 970 (27.13%) in the validation sample who were diagnosed with gastric atrophy. The nomogram predicting OLGA any-stage had an area under the curve (AUC) of 0.610 for the training sample and 0.615 for the validation sample, with favorable calibrations in the overall population. Similarly, the nomogram predicting OLGA stages III–IV had an AUC of 0.702 and 0.714 for the training and validation samples, respectively, with favorable calibrations in the overall population.Conclusions: The prediction model can early identify the occurrence of gastric atrophy and the severity stage of gastric atrophy to some extent.

Highlights

  • Gastric cancer (GC) is a malignant tumor, which is the fifth most common diagnosed cancer and the third cause of death, causes serious disease burden [1]

  • There were 1,226 (28.05%) participants in the training sample and 970 (27.13%) in the validation sample who were diagnosed with gastric atrophy

  • The nomogram predicting Operative link for gastritis assessment (OLGA) any-stage had an area under the curve (AUC) of 0.610 for the training sample and 0.615 for the validation sample, with favorable calibrations in the overall population

Read more

Summary

Introduction

Gastric cancer (GC) is a malignant tumor, which is the fifth most common diagnosed cancer and the third cause of death, causes serious disease burden [1]. It is a precancerous disease that predisposes to the development of gastric cancer, and the risk of gastric cancer is raised in patients with advanced AG [4]. The OLGA system has designated high-risk stages III–IV as precancerous lesions which deserves special follow-up [6, 7]. Serological tests, such as gastrin 17 (G-17) and pepsinogen (PG), can help identify cases at risk for AG. G-17 is an important gastrointestinal peptide hormone produced by G cells in gastric antrum, which is related to the location and degree of gastric mucosal atrophy [10].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call